Keeping with the trend of combining companies to help financially constrained biotechs stay afloat, investment major Syncona has again come to the rescue of Freeline Therapeutics Holdings PLC and merged the firm with fellow gene therapy specialist SwanBio Therapeutics.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?